Showing results (531-540 of 632) with videos related to

Sort By:
Pageof 64
The Lancet. HIV|May 8, 2018
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort studyLene Ryom, Jens D Lundgren, Wafaa El-Sadr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2016
Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort StudyLars I Gjærde, Leah Shepherd, Elzbieta Jablonowska, et al.
AIDS (London, England)|June 24, 2003
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD studyNina Friis-Møller, Rainer Weber, Peter Reiss, et al.
European Journal of Haematology|January 14, 2022
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?Christian Brieghel, Veerle Galle, Rudi Agius, et al.
Eclinicalmedicine|September 14, 2019
Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort StudyCamilla Ingrid Hatleberg, Lene Ryom, David Kamara, et al.
Scientific Reports|December 5, 2022
Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia scoreChristian M Jensen, Junia C Costa, Jens C Nørgaard, et al.
AIDS (London, England)|June 3, 2011
Elevated triglycerides and risk of myocardial infarction in HIV-positive personsSigne W Worm, David A Kamara, Peter Reiss, et al.
AIDS (London, England)|October 14, 2017
Abacavir use and risk of recurrent myocardial infarctionCaroline A Sabin, Lene Ryom, Antonella d'Arminio Monforte, et al.
AIDS (London, England)|December 6, 2022
Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIVDaniel D Murray, Birgit Grund, Cameron R MacPherson, et al.
The Journal of Infectious Diseases|August 23, 2003
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 TrialUlrik Bak Dragsted, Jan Gerstoft, Court Pedersen, et al.
Pageof 64